UnitedHealth Group Incorporated $UNH Shares Bought by Mayflower Financial Advisors LLC

Mayflower Financial Advisors LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 29.1% in the second quarter, HoldingsChannel.com reports. The fund owned 5,259 shares of the healthcare conglomerate’s stock after acquiring an additional 1,184 shares during the quarter. Mayflower Financial Advisors LLC’s holdings in UnitedHealth Group were worth $1,641,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd lifted its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 50 shares during the period. Glass Jacobson Investment Advisors llc lifted its holdings in shares of UnitedHealth Group by 80.9% in the 2nd quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 55 shares during the period. Kentucky Trust Co raised its holdings in UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after purchasing an additional 50 shares during the period. Finally, O Brien Wealth Partners LLC raised its holdings in UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on UNH. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 24th. Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Truist Financial increased their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Finally, Piper Sandler set a $417.00 target price on UnitedHealth Group and gave the company an “overweight” rating in a report on Tuesday. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $389.29.

View Our Latest Analysis on UNH

UnitedHealth Group Price Performance

UNH stock opened at $368.74 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business has a 50 day simple moving average of $340.88 and a 200-day simple moving average of $332.70. The firm has a market capitalization of $333.95 billion, a PE ratio of 15.98, a price-to-earnings-growth ratio of 2.37 and a beta of 0.47. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the business earned $7.15 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.